# Rivastigmine for Intensive Care Unit (ICU) Delirium

> **NCT00704301** · PHASE4 · TERMINATED · sponsor: **UMC Utrecht** · enrollment: 104 (actual)

## Conditions studied

- Delirium

## Interventions

- **DRUG:** Rivastigmine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00704301
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-11
- **Primary completion:** 2010-04
- **Final completion:** 2010-05
- **Target enrollment:** 104 (ACTUAL)
- **Why stopped:** The study is prematurely terminated due to a safety issue
- **Last updated:** 2010-08-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00704301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00704301, "Rivastigmine for Intensive Care Unit (ICU) Delirium". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00704301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*